Literature DB >> 17722906

The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism.

David M Mutch1, Bernward Klocke, Peter Morrison, Carol A Murray, Colin J Henderson, Martin Seifert, Gary Williamson.   

Abstract

To elucidate the role of hepatic cytochrome P450 oxidoreductase (POR) in lipid metabolism, we characterized perturbations in lipid homeostasis in a mouse model deficient in liver POR. Using an integrative approach in which transcriptomics, lipidomics, and various bioinformatic algorithms were employed, a disruption in liver lipid mobilization, oxidation, and electron transport functions were identified. Analyzing the promoters of genes in these biological processes identified common binding motifs for nuclear receptors sensitive to lipid status, while Srebp-1c binding sites were only identified in genes involved in lipid metabolism. POR-null mice had drastic increases in hepatic lipid content (diacylglycerols, triacylglycerols, phosphatidylcholine, and cholesterol esters) and a specific enrichment in n-7 and n-9 monounsaturated fatty acids (FAs). It was found that while transporters involved in peroxisomal FA oxidation were induced, mitochondrial oxidation appeared to be more tightly controlled, supporting the increase in monounsaturated FAs. Genes coding for hepatic transporters were differentially expressed, where lipid uptake was induced and efflux repressed, indicating that in the absence of hepatic POR the liver serves as a lipid reservoir. Furthermore, while significant changes in intestinal gene expression were found in POR-deficient mice, only minor changes to plasma and intestinal lipid content were observed. Thus, while liver POR plays an important role regulating gene expression and lipid metabolism locally, the hepatic deficiency of this enzyme reverberates throughout the biological system and produces a coordinated response to the low levels of circulating cholesterol and bile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17722906     DOI: 10.1021/pr0700448

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  14 in total

Review 1.  Biomarkers in nutritional epidemiology: applications, needs and new horizons.

Authors:  Mazda Jenab; Nadia Slimani; Magda Bictash; Pietro Ferrari; Sheila A Bingham
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

2.  Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid.

Authors:  James A Akingbasote; Alison J Foster; Huw B Jones; Rhiannon David; Nigel J Gooderham; Ian D Wilson; J Gerry Kenna
Journal:  Toxicol Res (Camb)       Date:  2016-11-09       Impact factor: 3.524

3.  Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.

Authors:  G P Holloway; C J Chou; J Lally; T Stellingwerff; A C Maher; O Gavrilova; M Haluzik; H Alkhateeb; M L Reitman; A Bonen
Journal:  Diabetologia       Date:  2011-03-26       Impact factor: 10.122

4.  Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.

Authors:  Todd D Porter; Subhashis Banerjee; Elzbieta I Stolarczyk; Ling Zou
Journal:  Drug Metab Dispos       Date:  2011-03-02       Impact factor: 3.922

5.  The role of cytochrome P450-dependent metabolism in the regulation of mouse hepatic growth hormone signaling components and target genes by 3-methylcholanthrene.

Authors:  Chunja Lee; Xinxin Ding; David S Riddick
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

6.  Potential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: novel link to expression of major histocompatibility complex class II genes.

Authors:  Jaime D'Agostino; Xinxin Ding; Peng Zhang; Kunzhi Jia; Cheng Fang; Yi Zhu; David C Spink; Qing-Yu Zhang
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

7.  Dysregulation of Npas2 leads to altered metabolic pathways in a murine knockout model.

Authors:  Derek O'Neil; Hector Mendez-Figueroa; Toni-Ann Mistretta; Chunliu Su; Robert H Lane; Kjersti M Aagaard
Journal:  Mol Genet Metab       Date:  2013-09-05       Impact factor: 4.797

Review 8.  Electron Transfer Pathways in Cholesterol Synthesis.

Authors:  Todd D Porter
Journal:  Lipids       Date:  2015-09-07       Impact factor: 1.880

9.  Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.

Authors:  Yi Zhu; Xinxin Ding; Cheng Fang; Qing-Yu Zhang
Journal:  Mol Pharmacol       Date:  2013-11-01       Impact factor: 4.436

10.  Quercetin induces hepatic lipid omega-oxidation and lowers serum lipid levels in mice.

Authors:  Elise F Hoek-van den Hil; Jaap Keijer; Annelies Bunschoten; Jacques J M Vervoort; Barbora Stankova; Melissa Bekkenkamp; Laure Herreman; Dini Venema; Peter C H Hollman; Eva Tvrzicka; Ivonne M C M Rietjens; Evert M van Schothorst
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.